Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
2,072,523
-
Shares change
-
+130,104
-
Total reported value, excl. options
-
$50,378,685
-
Value change
-
+$43,577
-
Number of buys
-
29
-
Number of sells
-
29
-
Price
-
$23.98
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q4 2018
As of 31 Dec 2018 ARK ETF TR - GENOMIC REV ETF (ARKG) had 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,072,523 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, Arlington Capital Management, Inc., LPL Financial LLC, Carroll Financial Associates, Inc., UBS Group AG, Financial Engines Advisors L.L.C., STEPHENS INC /AR/, Cambridge Investment Research Advisors, Inc., Snowden Capital Advisors LLC, and HighTower Advisors, LLC.
This table shows 73 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.